Table 2.
Demographic and baseline clinical characteristics of patients
| R-rRYGB N = 150 |
L-rRYGB N = 44 |
P | |
|---|---|---|---|
| Mean age (years) | 49.0 ± 10.1 | 48. 0 ± 10.5 | 1.0 |
| Gender (n, %) | |||
| Male | 12 (8.0%) | 11 (25.0%) | 0.006 |
| Female | 138 (92.0%) | 33 (75.0%) | |
| Mean weight (kg) | 94.2 ± 23.1 | 105.2 ± 25.4 | 0.007 |
| Mean BMI (kg/m2) | 35.6 ± 7.2 | 38.0 ± 8.5 | 0.06 |
| Comorbidities | |||
| Hypertension | 51 (34.0%) | 18 (40.9%) | 0.47 |
| Diabetes | 6 (4.0%) | 6 (13.6%) | 0.03 |
| OSAS | 13 (8.7%) | 4 (9.1%) | 1.0 |
| Dyslipidemia | 6 (4.0%) | 2 (4.5%) | 1.0 |
| Esophagogastroduodenoscopy | |||
| Esophagitis | 46 (30.7%) | 8 (18.2%) | 0.12 |
| HP infection | 8 (5.3%) | 0 (0%) | 0.20 |
| Hiatal hernia | 37 (24.7%) | 11 (25.0%) | 1.0 |
| Barrett’s esophagus | 1 (0.7%) | 0 (0%) | 1.0 |
| Index bariatric procedure | |||
| Adjustable gastric banding | 27 (18%) | 8 (18.2%) | 1.0 |
| Vertical banded gastroplasty | 74 (49.3%) | 31 (70.4%) | 0.016 |
| Sleeve gastrectomy | 49 (32.7%) | 5 (11.4%) | 0.007 |
| Indication for revisional surgery | |||
| Insufficient weight loss | 16 (10.7%) | 7 (15.9%) | 0.42 |
| Weight regain | 47 (31.3%) | 18 (40.9%) | 0.27 |
| Gastroesophageal reflux | 38 (25.3%) | 5 (11.4%) | 0.06 |
| Dysphagia | 49 (32.6%) | 14 (31.8%) | 1.0 |
R-rRYGB robotic revisional Roux-en-Y gastric bypass, L-r-RYGB laparoscopic revisional Roux-en-Y-gastric bypass, BMI body mass index, OSAS obstructive sleep apnea syndrome, HP helicobacter pylori